Skip to content

Myoelectric Upper Limb Orthosis Use by Persons With TBI and Stroke

Longitudinal Observation of Myoelectric Upper Limb Orthosis Use Among Veterans With Upper Limb Impairment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03215771
Enrollment
16
Registered
2017-07-12
Start date
2016-12-31
Completion date
2020-06-12
Last updated
2021-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Traumatic Brain Injury

Brief summary

The objective of this study was to document longitudinal outcomes in persons with traumatic brain injury (TBI) or stroke using the myoelectric upper limb orthosis with powered elbow and grasp in conjunction with motor learning-based therapy using both patient centric performance and patient reported outcome measures. Longitudinal observation allowed the investigators to detect both the initial therapeutic effects as well as the later functional outcomes of orthosis use. The investigators planned to recruit 15 Veterans and non-veterans who had TBI or stroke and upper limb impairment. The study required 29 visits over 22 weeks and was divided into three parts: orthotic fitting, therapy/training (9 weeks), and home use (9 weeks). Therapeutic and functional benefits were evaluated every 2 to 3 weeks over 18 weeks using simple, short clinical tests.

Detailed description

This study had two aims: (1) to evaluate therapeutic and neuroplastic effects of a myoelectric upper limb orthosis in conjunction with motor learning-based therapy and (2) to evaluate the functional effects of a myoelectric upper limb orthosis in conjunction with motor learning-based therapy. The investigators planned to recruit 15 Veterans and non-veterans who had Traumatic Brain Injury (TBI) or stroke and upper limb impairment, were over 18 years of age and a minimum of 6 months from injury. The study required 29 visits over 22 weeks and was divided into three parts: orthotic fitting, therapy/training (9 weeks), and home use (9 weeks). Therapeutic and functional benefits were evaluated every 2 to 3 weeks over 18 weeks using simple, short clinical tests. Subjects were enrolled in the study if they met eligibility criteria assessed at a screening visit. Once enrolled subjects were fit with a custom fabricated MyoPro Motion-G elbow-wrist-hand orthosis following standard clinical procedures. This process required up to three visits to cast, trial fit and deliver the orthosis. Subjects then participated in a standard-of-care motor learning based therapy protocol in conjunction with the PERL (Push Eat Reach Lift) training program recommended by Myomo, which consists of a 9 week, 18 session training plan. Every second week, there was one session that combined therapy/training and outcomes evaluation.

Interventions

DEVICEMyoPro Motion-G

The MyoPro Motion-G is an elbow-wrist-hand myoelectric orthosis.

OTHERMotor Learning-Based Therapy

Motor learning-based (MLB) therapy included movement practice as close to normal as possible, high repetition, progression of challenge, part versus whole task practice, and knowledge of results. Treatment was customized to abilities of each subject and consisted of both MyoPro training and MLB therapy without device. Training with device was progressed using a hierarchy of challenge to increase complexity of movement. MLB therapy without device followed the same hierarchy, incorporating training of movements that could not be accomplished with the device and those that were trained with device. Movement quality was monitored and training practice was incrementally progressed as subject demonstrated improved ability to perform a given task/movement component. Subjects performed a custom home exercise program (HEP) on non-clinic days, increasing repetition as tolerated. At conclusion of in-clinic phase, individuals transitioned to a home phase where they continued to use the HEP.

Sponsors

Louis Stokes VA Medical Center
CollaboratorFED
Myomo
CollaboratorINDUSTRY
Northwestern University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years of age * minimum 6 months since injury * elbow, forearm, wrist and hand have full motion with little resistance from muscles when moved by someone else * some ability to actively move the shoulder * able to generate consistent and detectable electrical signals from the upper arm and forearm muscles * able to read and comprehend the English language * able to follow two-stage command * cognitive abilities sufficient to perform testing and training protocols * able to tolerate functional tasks for 60 minutes without excessive fatigue * medically and psychologically stable * at home support from a family member or care giver if needed

Exclusion criteria

* elbow, forearm, wrist and hand have less than full motion with high resistance from muscles when moved by someone else * shoulder instability, pain or dislocation * unable to safely support the weight of arm with added weight of the device without pain * less than 12 weeks since botulinum toxin injection in the impaired arm * new therapies/medications planned during study period * skin rash or open wound on impaired arm * inability to detect light touch or pain on impaired arm * involuntary movements of the impaired arm * pain or hypersensitivity in the impaired arm * inability to understand English

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment of Motor Recovery for Upper Limb (FMA)Change in Fugl-Meyer Assessment of Motor Recovery for Upper Limb (FMA) from Baseline at Week 18Evaluation of motor impairment of the upper limb. Thirty-three items of movement coordination and reflex activity are scored with a 3-point Likert scale (0-66 points total) where higher scores represent less arm impairment.

Secondary

MeasureTime frameDescription
Modified Ashworth ScaleChange in Modified Ashworth Scale from Baseline at Week 18Using a 6-point scale, the clinician evaluates resistance to passive movement about a joint with varying degrees of velocity as follows: 0 No increase in muscle tone. 1 Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension. 1+ Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM. 2 More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved. 3 Considerable increase in muscle tone, passive movement difficult. 4 Affected part(s) rigid in flexion or extension. A lower score represents less resistance to passive movement.
Chedoke Arm and Hand Activity Inventory (CAHAI)Change in Chedoke Arm and Hand Activity Inventory (CAHAI) from Baseline at Week 18Used to assess performance of activities of daily living (ADLs). Measure consists of 13 functional tasks scores and the score for each functional task are summed to compute the total score. Scoring of each task is based on a 7-point scale (1=unable; 7=normal performance; minimum score is 13 points; maximum score is 91 points), where higher scores represent better performance of ADLs.
Orthotic and Prosthetic Users' Survey Satisfaction Module (OPUSsat)Change in Orthotic and Prosthetic Users' Survey satisfaction module (OPUSsat) from Baseline at Week 18An 11-item patient-reported survey that assesses satisfaction with device using a 5-point Likert scale. Satisfaction with device is the sum of the scores (score range: 11-55), where higher scores indicate better satisfaction with device.
Craig Handicap Assessment and Rehabilitation Technique (CHART)Change in Craig Handicap Assessment and Rehabilitation Technique (CHART) from Baseline at Week 18A life-role participation survey measuring the level of handicap using objectively observable behaviors in five dimensions: physical, social, cognitive, mobility, and occupation. Survey responses are combined using formulas for each domain. The score in each domain is capped at 100 (total score range: 0-500). Higher scores represent better self-reported participation.

Countries

United States

Participant flow

Participants by arm

ArmCount
MyoPro + Motor Based Learning
Subjects received 9 weeks of motor based therapy in combination with use of MyoPro myoelectric elbow wrist hand orthosis, followed by 9 weeks of home use with a customized exercise program. MyoPro Motion-G: The MyoPro Motion-G is a custom-fabricated elbow-wrist-hand myoelectric orthosis.
13
Total13

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPhysician Decision1
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicMyoPro + Motor Based Learning
Age, Continuous50.62 years
STANDARD_DEVIATION 19.91
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 13
other
Total, other adverse events
0 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Fugl-Meyer Assessment of Motor Recovery for Upper Limb (FMA)

Evaluation of motor impairment of the upper limb. Thirty-three items of movement coordination and reflex activity are scored with a 3-point Likert scale (0-66 points total) where higher scores represent less arm impairment.

Time frame: Change in Fugl-Meyer Assessment of Motor Recovery for Upper Limb (FMA) from Baseline at Week 18

Population: combined results from 6 TBI and 7 stroke subjects

ArmMeasureValue (MEAN)
MyoPro + Motor Based LearningFugl-Meyer Assessment of Motor Recovery for Upper Limb (FMA)7.5 score on a scale
Secondary

Chedoke Arm and Hand Activity Inventory (CAHAI)

Used to assess performance of activities of daily living (ADLs). Measure consists of 13 functional tasks scores and the score for each functional task are summed to compute the total score. Scoring of each task is based on a 7-point scale (1=unable; 7=normal performance; minimum score is 13 points; maximum score is 91 points), where higher scores represent better performance of ADLs.

Time frame: Change in Chedoke Arm and Hand Activity Inventory (CAHAI) from Baseline at Week 18

Population: combined results from 6 TBI and 7 stroke subjects

ArmMeasureValue (MEAN)
MyoPro + Motor Based LearningChedoke Arm and Hand Activity Inventory (CAHAI)8.8 score on a scale
Secondary

Craig Handicap Assessment and Rehabilitation Technique (CHART)

A life-role participation survey measuring the level of handicap using objectively observable behaviors in five dimensions: physical, social, cognitive, mobility, and occupation. Survey responses are combined using formulas for each domain. The score in each domain is capped at 100 (total score range: 0-500). Higher scores represent better self-reported participation.

Time frame: Change in Craig Handicap Assessment and Rehabilitation Technique (CHART) from Baseline at Week 18

ArmMeasureValue (MEAN)
MyoPro + Motor Based LearningCraig Handicap Assessment and Rehabilitation Technique (CHART)34.9 score on a scale
Secondary

Modified Ashworth Scale

Using a 6-point scale, the clinician evaluates resistance to passive movement about a joint with varying degrees of velocity as follows: 0 No increase in muscle tone. 1 Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension. 1+ Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM. 2 More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved. 3 Considerable increase in muscle tone, passive movement difficult. 4 Affected part(s) rigid in flexion or extension. A lower score represents less resistance to passive movement.

Time frame: Change in Modified Ashworth Scale from Baseline at Week 18

Population: combined results from 6 TBI and 7 stroke subjects

ArmMeasureValue (MEAN)
MyoPro + Motor Based LearningModified Ashworth Scale-2.3 score on a scale
Secondary

Orthotic and Prosthetic Users' Survey Satisfaction Module (OPUSsat)

An 11-item patient-reported survey that assesses satisfaction with device using a 5-point Likert scale. Satisfaction with device is the sum of the scores (score range: 11-55), where higher scores indicate better satisfaction with device.

Time frame: Change in Orthotic and Prosthetic Users' Survey satisfaction module (OPUSsat) from Baseline at Week 18

Population: combined results from 6 TBI and 7 stroke subjects

ArmMeasureValue (MEAN)
MyoPro + Motor Based LearningOrthotic and Prosthetic Users' Survey Satisfaction Module (OPUSsat)26.7 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026